{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:36:02Z","timestamp":1789752962184,"version":"4.0.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A5A2021242"],"award-info":[{"award-number":["2018R1A5A2021242"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00338876"],"award-info":[{"award-number":["RS-2024-00338876"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sungshin Women\u2019s University Research Grant","award":["H20230062"],"award-info":[{"award-number":["H20230062"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-025-03139-9","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T12:47:48Z","timestamp":1754916468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors for tuberculosis treatment outcomes: a statistical learning-based exploration using the SINAN database with incomplete observations"],"prefix":"10.1186","volume":"25","author":[{"given":"Nguyen Ky","family":"Phat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh Hoa","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Phuoc","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongoh","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"3139_CR1","doi-asserted-by":"crossref","unstructured":"Ranzani OT, Pescarini JM, Martinez L, Garcia-Basteiro AL. Increasing tuberculosis burden in Latin america: an alarming trend for global control efforts. BMJ Glob Health. 2021;6(3).","DOI":"10.1136\/bmjgh-2021-005639"},{"issue":"2","key":"3139_CR2","doi-asserted-by":"publisher","first-page":"e20200119","DOI":"10.36416\/1806-3756\/e20200119","volume":"47","author":"AO Cortez","year":"2021","unstructured":"Cortez AO, Melo AC, Neves LO, Resende KA, Camargos P. Tuberculosis in brazil: one country, multiple realities. J Bras Pneumol. 2021;47(2):e20200119.","journal-title":"J Bras Pneumol"},{"key":"3139_CR3","doi-asserted-by":"crossref","unstructured":"Kohler S, Sitali N, Achar J, Paul N. Programme costs of longer and shorter tuberculosis drug regimens and drug import: a modelling study for karakalpakstan, Uzbekistan. ERJ Open Res. 2022;8(1).","DOI":"10.1183\/23120541.00622-2021"},{"issue":"10202","key":"3139_CR4","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(19)31882-3","volume":"394","author":"C Lange","year":"2019","unstructured":"Lange C, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR Jr. Management of drug-resistant tuberculosis. Lancet. 2019;394(10202):953\u201366.","journal-title":"Lancet"},{"issue":"5","key":"3139_CR5","first-page":"CD003343","volume":"2015","author":"J Karumbi","year":"2015","unstructured":"Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2015;2015(5):CD003343.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3139_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1128\/AAC.00749-08","volume":"53","author":"J van den Boogaard","year":"2009","unstructured":"van den Boogaard J, Kibiki GS, Kisanga ER, Boeree MJ, Aarnoutse RE. New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development. Antimicrob Agents Chemother. 2009;53(3):849\u201362.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3139_CR7","doi-asserted-by":"publisher","first-page":"e044687","DOI":"10.1136\/bmjopen-2020-044687","volume":"11","author":"LS Peetluk","year":"2021","unstructured":"Peetluk LS, Ridolfi FM, Rebeiro PF, Liu D, Rolla VC, Sterling TR. Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults. BMJ Open. 2021;11(3):e044687.","journal-title":"BMJ Open"},{"key":"3139_CR8","doi-asserted-by":"crossref","unstructured":"Calderwood CJ, Sanchez Martinez A, Greenan-Barrett J, Turner CT, Oguti B, Roe JK, Gupta R, Martineau AR, Noursadeghi M. Resolution of tuberculosis blood RNA signatures fails to discriminate persistent sputum culture positivity after eight weeks of anti-tuberculous treatment. Eur Respir J. 2024.","DOI":"10.1101\/2023.11.24.23298983"},{"key":"3139_CR9","doi-asserted-by":"publisher","first-page":"104173","DOI":"10.1016\/j.ebiom.2022.104173","volume":"82","author":"CLR van Doorn","year":"2022","unstructured":"van Doorn CLR, Eckold C, Ronacher K, Ruslami R, van Veen S, Lee JS, Kumar V, Kerry-Barnard S, Malherbe ST, Kleynhans L, et al. Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment. EBioMedicine. 2022;82:104173.","journal-title":"EBioMedicine"},{"issue":"11","key":"3139_CR10","doi-asserted-by":"publisher","first-page":"e0207491","DOI":"10.1371\/journal.pone.0207491","volume":"13","author":"CM Sauer","year":"2018","unstructured":"Sauer CM, Sasson D, Paik KE, McCague N, Celi LA, Sanchez Fernandez I, Illigens BMW. Feature selection and prediction of treatment failure in tuberculosis. PLoS ONE. 2018;13(11):e0207491.","journal-title":"PLoS ONE"},{"key":"3139_CR11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.procs.2023.01.424","volume":"219","author":"ACA Mioto","year":"2023","unstructured":"Mioto ACA, Mozini MT, Segamarchi RB, Soares GT, Martins PEA, Cass\u00e3o V, Ferrassini LGB, Miyoshi NSB, Alves D, de Oliveira LL. Preliminary results to predict tuberculosis outcomes applying traditional and automated machine learning models. Procedia Comput Sci. 2023;219:1365\u201372.","journal-title":"Procedia Comput Sci"},{"key":"3139_CR12","doi-asserted-by":"crossref","unstructured":"Liao KM, Liu CF, Chen CJ, Feng JY, Shu CC, Ma YS. Using an artificial intelligence approach to predict the adverse effects and prognosis of tuberculosis. Diagnostics (Basel). 2023;13(6).","DOI":"10.3390\/diagnostics13061075"},{"issue":"2","key":"3139_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/17538157.2018.1433676","volume":"44","author":"OA Hussain","year":"2019","unstructured":"Hussain OA, Junejo KN. Predicting treatment outcome of drug-susceptible tuberculosis patients using machine-learning models. Inf Health Soc Care. 2019;44(2):135\u201351.","journal-title":"Inf Health Soc Care"},{"issue":"1","key":"3139_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41597-022-01892-4","volume":"9","author":"MH Barros","year":"2022","unstructured":"Lino Ferreira da Silva, Barros MH, Santos GL, de Almeida Rodrigues MG, Sampaio V, Lynn T, Endo PT. A Brazilian classified data set for prognosis of tuberculosis, between January 2001 and April 2020. Sci Data. 2022;9(1):771.","journal-title":"Sci Data"},{"issue":"2","key":"3139_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/informatics8020027","volume":"8","author":"MH Barros","year":"2021","unstructured":"Lino Ferreira da Silva, Barros MH, Geovanne OA, Lubnnia MFS, Elisson DSR, Oliveira JFLD, Lynn T, Sampaio V, Endo PT. Benchmarking machine learning models to assist in the prognosis of tuberculosis. Informatics. 2021;8(2):27.","journal-title":"Informatics"},{"key":"3139_CR16","doi-asserted-by":"crossref","unstructured":"Foh WLW, Ang SL, Lim CY, Alaga AAL, Yeap GH. Prediction of tuberculosis patients\u2019 treatment outcomes using multinomial naive bayes algorithm and class-imbalanced data. In: 2023 IEEE IAS Global Conference on Emerging Technologies (GlobConET): 19\u201321 May 2023: IEEE. 2023:1\u20136.","DOI":"10.1109\/GlobConET56651.2023.10150132"},{"key":"3139_CR17","doi-asserted-by":"crossref","unstructured":"Lino Ferreira da Silva, Barros MH, Santos G, Sampaio V, Lynn T, Endo PT. A Brazilian classified dataset for prognosis of tuberculosis. In.: Mendeley Data; 2022.","DOI":"10.1038\/s41597-022-01892-4"},{"key":"3139_CR18","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3389\/fphar.2017.00961","volume":"8","author":"RE da Silva","year":"2017","unstructured":"da Silva RE, Amato AA, Guilhem DB, de Carvalho MR, Novaes M. International clinical trials in Latin American and Caribbean countries: research and development to Meet local health needs. Front Pharmacol. 2017;8:961.","journal-title":"Front Pharmacol"},{"key":"3139_CR19","unstructured":"Harrell FE Jr. Hmisc: harrell miscellaneous. R package version 5.1-0. 2023. https:\/\/CRAN.R-project.org\/package=Hmisc"},{"issue":"3","key":"3139_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1\u201367.","journal-title":"J Stat Softw"},{"key":"3139_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1201\/b11826","volume-title":"Flexible imputation of missing data","author":"S Van Buuren","year":"2012","unstructured":"Van Buuren S. Chap. 2.7: how many imputations. Flexible imputation of missing data. 1st ed. New York: CRC Press. 2012. pp. 49\u201351.","edition":"1"},{"key":"3139_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1201\/b11826","volume-title":"Flexible imputation of missing data","author":"S Van Buuren","year":"2012","unstructured":"Van Buuren S. Chap. 4.5.5: number of iterations. Flexible imputation of missing data. 1st ed. New York: CRC Press. 2012. pp. 112\u20133.","edition":"1"},{"issue":"1","key":"3139_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v077.i01","volume":"77","author":"MN Wright","year":"2017","unstructured":"Wright MN, Ziegler A. Ranger: A fast implementation of random forests for high dimensional data in C\u2009+\u2009+\u2009and R. J Stat Softw. 2017;77(1):1\u201317.","journal-title":"J Stat Softw"},{"key":"3139_CR24","unstructured":"Greenwell B, Boehmke B, Cunningham J, Developers GBM. gbm: Generalized boosted regression models. R package version 2.1.9. 2024. https:\/\/CRAN.R-project.org\/package=gbm"},{"key":"3139_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"D Rubin","year":"1987","unstructured":"Rubin D. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987."},{"key":"3139_CR26","doi-asserted-by":"publisher","first-page":"104174","DOI":"10.1016\/j.ebiom.2022.104174","volume":"82","author":"Y Hamada","year":"2022","unstructured":"Hamada Y, Penn-Nicholson A, Krishnan S, Cirillo DM, Matteelli A, Wyss R, Denkinger CM, Rangaka MX, Ruhwald M, Schumacher SG. Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? - A review of evidence and the technological landscape. EBioMedicine. 2022;82:104174.","journal-title":"EBioMedicine"},{"issue":"7","key":"3139_CR27","doi-asserted-by":"publisher","first-page":"e1010770","DOI":"10.1371\/journal.pcbi.1010770","volume":"19","author":"R Vargas","year":"2023","unstructured":"Vargas R, Abbott L, Bower D, Frahm N, Shaffer M, Yu WH. Gene signature discovery and systematic validation across diverse clinical cohorts for TB prognosis and response to treatment. PLoS Comput Biol. 2023;19(7):e1010770.","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"3139_CR28","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/sim.9275","volume":"41","author":"RD Riley","year":"2022","unstructured":"Riley RD, Collins GS, Ensor J, Archer L, Booth S, Mozumder SI, Rutherford MJ, van Smeden M, Lambert PC, Snell KIE. Minimum sample size calculations for external validation of a clinical prediction model with a time-to-event outcome. Stat Med. 2022;41(7):1280\u201395.","journal-title":"Stat Med"},{"key":"3139_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1201\/b11826","volume-title":"Flexible imputation of missing data","author":"S Van Buuren","year":"2012","unstructured":"Van Buuren S. Chap. 2.6: when to use multiple imputation. Flexible imputation of missing data. 1st ed. New York: CRC Press. 2012. pp. 48\u20139.","edition":"1"},{"issue":"4","key":"3139_CR30","first-page":"538","volume":"9","author":"X Meng","year":"1994","unstructured":"Meng X. Multiple-Imputation inferences with uncongenial sources of input. Stat Sci. 1994;9(4):538\u201373.","journal-title":"Stat Sci"},{"issue":"4","key":"3139_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1037\/1082-989X.6.4.330","volume":"6","author":"LM Collins","year":"2001","unstructured":"Collins LM, Schafer JL, Kam C-MJP. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods. 2001;6(4):330.","journal-title":"Psychol Methods"},{"key":"3139_CR32","unstructured":"World Health Organization. Global tuberculosis report 2023. In. Geneva. 2023."},{"issue":"4","key":"3139_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/thx.2005.049452","volume":"61","author":"ME Jimenez-Corona","year":"2006","unstructured":"Jimenez-Corona ME, Garcia-Garcia L, DeRiemer K, Ferreyra-Reyes L, Bobadilla-del-Valle M, Cano-Arellano B, Canizales-Quintero S, Martinez-Gamboa A, Small PM, Sifuentes-Osornio J, et al. Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area. Thorax. 2006;61(4):348\u201353.","journal-title":"Thorax"},{"issue":"1","key":"3139_CR34","first-page":"52","volume":"18","author":"R Alavi-Naini","year":"2013","unstructured":"Alavi-Naini R, Moghtaderi A, Metanat M, Mohammadi M, Zabetian M. Factors associated with mortality in tuberculosis patients. J Res Med Sci. 2013;18(1):52\u20135.","journal-title":"J Res Med Sci"},{"issue":"9","key":"3139_CR35","doi-asserted-by":"publisher","first-page":"E331","DOI":"10.1111\/j.1469-0691.2012.03931.x","volume":"18","author":"JY Feng","year":"2012","unstructured":"Feng JY, Huang SF, Ting WY, Chen YC, Lin YY, Huang RM, Lin CH, Hwang JJ, Lee JJ, Yu MC, et al. Gender differences in treatment outcomes of tuberculosis patients in taiwan: a prospective observational study. Clin Microbiol Infect. 2012;18(9):E331\u2013337.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"3139_CR36","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1440-1843.2010.01784.x","volume":"15","author":"HS Schaaf","year":"2010","unstructured":"Schaaf HS, Collins A, Bekker A, Davies PD. Tuberculosis at extremes of age. Respirology. 2010;15(5):747\u201363.","journal-title":"Respirology"},{"key":"3139_CR37","doi-asserted-by":"crossref","unstructured":"Caraux-Paz P, Diamantis S, de Wazieres B, Gallien S. Tuberculosis in the elderly. J Clin Med. 2021;10(24).","DOI":"10.3390\/jcm10245888"},{"key":"3139_CR38","volume-title":"Treatment of tuberculosis: guidelines","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. Geneva: World Health Organization; 2010.","edition":"4"},{"key":"3139_CR39","doi-asserted-by":"publisher","first-page":"100263","DOI":"10.1016\/j.jctube.2021.100263","volume":"24","author":"EM Bukundi","year":"2021","unstructured":"Bukundi EM, Mhimbira F, Kishimba R, Kondo Z, Moshiro C. Mortality and associated factors among adult patients on tuberculosis treatment in tanzania: A retrospective cohort study. J Clin Tuberc Other Mycobact Dis. 2021;24:100263.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"1","key":"3139_CR40","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/s12879-022-07598-7","volume":"22","author":"I Bykov","year":"2022","unstructured":"Bykov I, Dyachenko O, Ratmanov P, Liu H, Liang L, Wu Q. Factors contributing to the high prevalence of multidrug-resistance\/Rifampicin-resistance in patients with tuberculosis: an epidemiological cross sectional and qualitative study from Khabarovsk Krai region of Russia. BMC Infect Dis. 2022;22(1):612.","journal-title":"BMC Infect Dis"},{"key":"3139_CR41","doi-asserted-by":"crossref","unstructured":"de Faria Gomes NM, da Mota Bastos MC, Marins RM, Barbosa AA, de Soares LC. Oliveira Wilken de Abreu AM, Souto filho JT: differences between risk factors associated with tuberculosis treatment abandonment and mortality. Pulm Med. 2015;2015:546106.","DOI":"10.1155\/2015\/546106"},{"issue":"4","key":"3139_CR42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1590\/S0102-311X2008000400020","volume":"24","author":"MP Domingos","year":"2008","unstructured":"Domingos MP, Caiaffa WT, Colosimo EA. Mortality, TB\/HIV co-infection, and treatment dropout: predictors of tuberculosis prognosis in recife, Pernambuco state, Brazil. Cad Saude Publica. 2008;24(4):887\u201396.","journal-title":"Cad Saude Publica"},{"issue":"10","key":"3139_CR43","doi-asserted-by":"publisher","first-page":"e384","DOI":"10.1371\/journal.pmed.0030384","volume":"3","author":"H Cox","year":"2006","unstructured":"Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, Stone C, Niemann S, Rusch-Gerdes S, Blok L, et al. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. PLoS Med. 2006;3(10):e384.","journal-title":"PLoS Med"},{"issue":"6","key":"3139_CR44","doi-asserted-by":"publisher","first-page":"e0268290","DOI":"10.1371\/journal.pone.0268290","volume":"17","author":"HM Youn","year":"2022","unstructured":"Youn HM, Shin MK, Jeong D, Kim HJ, Choi H, Kang YA. Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study. PLoS ONE. 2022;17(6):e0268290.","journal-title":"PLoS ONE"},{"issue":"2","key":"3139_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4046\/trd.2015.78.2.47","volume":"78","author":"JY Lee","year":"2015","unstructured":"Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2015;78(2):47\u201355.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"4","key":"3139_CR46","first-page":"EE01","volume":"9","author":"M Purohit","year":"2015","unstructured":"Purohit M, Mustafa T. Laboratory diagnosis of Extra-pulmonary tuberculosis (EPTB) in Resource-constrained setting: state of the art, challenges and the need. J Clin Diagn Res. 2015;9(4):EE01\u201306.","journal-title":"J Clin Diagn Res"},{"issue":"7","key":"3139_CR47","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1007\/s00415-022-11052-8","volume":"269","author":"A Navarro-Flores","year":"2022","unstructured":"Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, Soriano-Moreno DR, Pacheco-Barrios K. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis. J Neurol. 2022;269(7):3482\u201394.","journal-title":"J Neurol"},{"issue":"1","key":"3139_CR48","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12879-020-05350-7","volume":"20","author":"HK Koo","year":"2020","unstructured":"Koo HK, Min J, Kim HW, Lee J, Kim JS, Park JS, Lee SS. Prediction of treatment failure and compliance in patients with tuberculosis. BMC Infect Dis. 2020;20(1):622.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"3139_CR49","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5588\/ijtld.11.0034","volume":"16","author":"YF Yen","year":"2012","unstructured":"Yen YF, Rodwell TC, Yen MY, Shih HC, Hu BS, Li LH, Shie YH, Chuang P, Garfein RS. DOT associated with reduced all-cause mortality among tuberculosis patients in taipei, taiwan, 2006\u20132008. Int J Tuberc Lung Dis. 2012;16(2):178\u201384.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3139_CR50","volume-title":"WHO consolidated guidelines on tuberculosis, module 4: Treatment - Drug-susceptible tuberculosis treatment","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis, module 4: treatment - drug-susceptible tuberculosis treatment. Geneva: World Health Organization; 2022."},{"issue":"6","key":"3139_CR51","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/cpt.2261","volume":"110","author":"CA Peloquin","year":"2021","unstructured":"Peloquin CA, Davies GR. The treatment of tuberculosis. Clin Pharmacol Ther. 2021;110(6):1455\u201366.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"3139_CR52","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5415\/apallergy.2014.4.3.156","volume":"4","author":"BY Thong","year":"2014","unstructured":"Thong BY, Chia FL, Tan SC, Tan TC, Leong KP, Tan JW, Tang CY, Hou JF, Chan GY, Chng HH. A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy. Asia Pac Allergy. 2014;4(3):156\u201363.","journal-title":"Asia Pac Allergy"},{"issue":"1","key":"3139_CR53","doi-asserted-by":"publisher","first-page":"ofad691","DOI":"10.1093\/ofid\/ofad691","volume":"11","author":"M Ara\u00fajo-Pereira","year":"2024","unstructured":"Ara\u00fajo-Pereira M, Arriaga MB, Carvalho ACC, Spener-Gomes R, Schmaltz CAS, Nogueira BMF, Figueiredo MC, Turner MM, Cordeiro-Santos M, Rolla VC, et al. Isoniazid monoresistance and antituberculosis treatment outcome in persons with pulmonary tuberculosis in Brazil. Open Forum Infect Dis. 2024;11(1):ofad691.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"3139_CR54","doi-asserted-by":"publisher","first-page":"MGM2","DOI":"10.1128\/microbiolspec.MGM2-0023-2013","volume":"2","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Shi W, Zhang W, Mitchison D. Mechanisms of Pyrazinamide action and resistance. Microbiol Spectr. 2014;2(4):MGM2\u20130023.","journal-title":"Microbiol Spectr"},{"key":"3139_CR55","doi-asserted-by":"crossref","unstructured":"Zhang N, Savic RM, Boeree MJ, Peloquin CA, Weiner M, Heinrich N, Bliven-Sizemore E, Phillips PPJ, Hoelscher M, Whitworth W et al. Optimising Pyrazinamide for the treatment of tuberculosis. Eur Respir J. 2021;58(1).","DOI":"10.1183\/13993003.02013-2020"},{"issue":"2","key":"3139_CR56","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1183\/09031936.00033010","volume":"37","author":"WW Yew","year":"2011","unstructured":"Yew WW, Lange C, Leung CC. Treatment of tuberculosis: update 2010. Eur Respir J. 2011;37(2):441\u201362.","journal-title":"Eur Respir J"},{"issue":"3","key":"3139_CR57","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1128\/AAC.01036-07","volume":"52","author":"CA Peloquin","year":"2008","unstructured":"Peloquin CA, Hadad DJ, Molino LP, Palaci M, Boom WH, Dietze R, Johnson JL. Population pharmacokinetics of levofloxacin, gatifloxacin, and Moxifloxacin in adults with pulmonary tuberculosis. Antimicrob Agents Chemother. 2008;52(3):852\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3139_CR58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s40265-018-1043-y","volume":"79","author":"AD Pranger","year":"2019","unstructured":"Pranger AD, van der Werf TS, Kosterink JGW, Alffenaar JWC. The role of fluoroquinolones in the treatment of tuberculosis in 2019. Drugs. 2019;79(2):161\u201371.","journal-title":"Drugs"},{"issue":"1","key":"3139_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1164\/rccm.202410-2096ST","volume":"211","author":"JJ Saukkonen","year":"2025","unstructured":"Saukkonen JJ, Duarte R, Munsiff SS, Winston CA, Mammen MJ, Abubakar I, Acu\u00f1a-Villaordu\u00f1a C, Barry PM, Bastos ML, Carr W, et al. Updates on the treatment of drug-susceptible and drug-resistant tuberculosis: an official ATS\/CDC\/ERS\/IDSA clinical practice guideline. Am J Respir Crit Care Med. 2025;211(1):15\u201333.","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"3139_CR60","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.3346\/jkms.2022.37.e128","volume":"37","author":"SJ Chung","year":"2022","unstructured":"Chung SJ, Byeon SJ, Choi JH. Analysis of adverse drug reactions to First-Line Anti-Tuberculosis drugs using the Korea adverse event reporting system. J Korean Med Sci. 2022;37(16):e128.","journal-title":"J Korean Med Sci"},{"key":"3139_CR61","first-page":"970203","volume":"2012","author":"W Ssengooba","year":"2012","unstructured":"Ssengooba W, Kateete DP, Wajja A, Bugumirwa E, Mboowa G, Namaganda C, Nakayita G, Nassolo M, Mumbowa F, Asiimwe BB, et al. An early morning sputum sample is necessary for the diagnosis of pulmonary tuberculosis, even with more sensitive techniques: A prospective cohort study among adolescent TB-Suspects in Uganda. Tuberc Res Treat. 2012;2012:970203.","journal-title":"Tuberc Res Treat"},{"issue":"1","key":"3139_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13244-021-01138-8","volume":"13","author":"MTA Wetscherek","year":"2022","unstructured":"Wetscherek MTA, Sadler TJ, Lee JYJ, Karia S, Babar JL. Active pulmonary tuberculosis: something old, something new, something borrowed, something blue. Insights Imaging. 2022;13(1):3.","journal-title":"Insights Imaging"},{"issue":"12","key":"3139_CR63","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.5588\/ijtld.20.0458","volume":"24","author":"G Lee","year":"2020","unstructured":"Lee G, Scuffell J, Galea JT, Shin SS, Magill E, Jaramillo E, Sweetland AC. Impact of mental disorders on active TB treatment outcomes: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2020;24(12):1279\u201384.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"3139_CR64","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2165\/00002018-199411040-00003","volume":"11","author":"JM Grange","year":"1994","unstructured":"Grange JM, Winstanley PA, Davies PD. Clinically significant drug interactions with antituberculosis agents. Drug Saf. 1994;11(4):242\u201351.","journal-title":"Drug Saf"},{"key":"3139_CR65","doi-asserted-by":"publisher","first-page":"962809","DOI":"10.3389\/fpubh.2022.962809","volume":"10","author":"D Weiangkham","year":"2022","unstructured":"Weiangkham D, Umnuaypornlert A, Saokaew S, Prommongkol S, Ponmark J. Effect of alcohol consumption on relapse outcomes among tuberculosis patients: a systematic review and meta-analysis. Front Public Health. 2022;10:962809.","journal-title":"Front Public Health"},{"issue":"1","key":"3139_CR66","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12879-018-3396-y","volume":"18","author":"B Myers","year":"2018","unstructured":"Myers B, Bouton TC, Ragan EJ, White LF, McIlleron H, Theron D, Parry CDH, Horsburgh CR, Warren RM, Jacobson KR. Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol. BMC Infect Dis. 2018;18(1):488.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3139_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5588\/ijtld.19.0080","volume":"24","author":"EJ Ragan","year":"2020","unstructured":"Ragan EJ, Kleinman MB, Sweigart B, Gnatienko N, Parry CD, Horsburgh CR, LaValley MP, Myers B, Jacobson KR. The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2020;24(1):73\u201382.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3139_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/CLEP.S129785","volume":"9","author":"AB Pedersen","year":"2017","unstructured":"Pedersen AB, Mikkelsen EM, Cronin-Fenton D, Kristensen NR, Pham TM, Pedersen L, Petersen I. Missing data and multiple imputation in clinical epidemiological research. Clin Epidemiol. 2017;9:157\u201366.","journal-title":"Clin Epidemiol"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03139-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-025-03139-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03139-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:22:04Z","timestamp":1757377324000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-025-03139-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3139"],"URL":"https:\/\/doi.org\/10.1186\/s12911-025-03139-9","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"301"}}